Picture this: Acres of cotton all around you. 150,000 plants. Now, harvest them all, collect the seeds — all 45 million of them — and start sequencing genomes.

Bruce Donald, Marcel Frenkel and Mark Hallen are analyzing over 19,290,123 compounds per second at quantum accuracies to develop drugs to previously incurable cancers.

Funded with $57 million from DCVC, Lowercarbon Capital and SOSV, among others, unspun aims to eliminate 1% of global carbon emissions

While it might look like a plant-based food company, NotCo is in the data and AI business—and aims to disrupt R&D in many industries that use animal and plant ingredients.

While volunteering in a Syrian refugee camp, stem cell biologist Deniz Kent saw what climate change could do to humanity at a massively greater scale. He co-founded Prolific Machines with Max Huisman and Declan Jones to address a top source of greenhouse gas emissions: livestock.

Gilberto Loureiro grew up inspecting fabrics in a Portuguese textile factory. With Smartex, he and co-founders Antonio Rocha and Paulo Ribeiro are eliminating textile defects—and their enormous cost both to manufacturers and the environment. 

Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had invented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually around the world and 100,000 in Africa.

Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.

It was 2015, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.

In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.